Almost 400 cures: ELIMINATE project successfully fights against hepatitis C in Vienna

Almost 400 cures: ELIMINATE project successfully fights against hepatitis C in Vienna

In a remarkable medical initiative called ELIMINATE, significant progress has been made in the fight against hepatitis C in Vienna and Lower Austria. Experienced teams from ten hospitals, including six clinics of the Vienna Hospital Association (WIGEV), systematically analyzed hospital data in order to identify affected people and treat them in a targeted manner.

These efforts have now successfully cured nearly 400 patients using modern therapies that effectively combat chronic hepatitis C disease. The impressive results of this comprehensive study were recently published in the highly respected journal “Liver International”. This publication not only represents a significant milestone in medical research, but also a glimmer of hope for many affected people.

Project goal and implementation

The ELIMINATE project was launched in 2020 with the long-term goal of eliminating hepatitis C in Eastern Austria. A large-scale investigation was carried out under the leadership of a competent team of doctors consisting of specialists from the Medical University of Vienna, the Ottakring Clinic and the Sankt Pölten University Hospital. The work of these medical professionals, including Lorenz Balcar and Michael Schwarz from MedUni Vienna and Caroline Schwarz and David Bauer from the Vienna Health Association, has now received international recognition.

Together with Livia Dorn and Andreas Maieron, who work at the University Hospital of Sankt Pölten, the teaching and research location of the Karl Landsteiner Private University, they have made significant progress in the treatment and understanding of hepatitis C. This research shows how important interdisciplinary collaboration is in medical science.

The findings from this study not only provide insights into effective treatment approaches, but also a comprehensive overview of the current situation of those affected by hepatitis C in the region. The project's successes and progress are a testament to the commitment and innovation invested in combating this widespread disease.

Another aspect of the ELIMINATE project is the important role of publication in a high-quality specialist journal. This scientific platform makes it possible to make the findings accessible to a broad public and thus raise awareness of the disease and its treatment. The results of this study are important not only for scientists, but also for all health institutions involved in the fight against hepatitis C.

To find out more about the results of the study, you can download the full study on medonline.at see. This detailed presentation of the results highlights the importance of continued research in the healthcare sector and the potential impact of these innovations on the lives of people affected by hepatitis C.